224 related articles for article (PubMed ID: 22155074)
1. Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values.
Escobar A; Gonzalez M; Quintana JM; Vrotsou K; Bilbao A; Herrera-Espiñeira C; Garcia-Perez L; Aizpuru F; Sarasqueta C
Osteoarthritis Cartilage; 2012 Feb; 20(2):87-92. PubMed ID: 22155074
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of estimates of the minimal clinically important difference and patient acceptable symptom state of the Western Ontario and McMaster Universities Osteoarthritis Index in patients who underwent total hip and total knee replacement.
MacKay C; Clements N; Wong R; Davis AM
Osteoarthritis Cartilage; 2019 Oct; 27(10):1408-1419. PubMed ID: 31096046
[TBL] [Abstract][Full Text] [Related]
3. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
[TBL] [Abstract][Full Text] [Related]
4. [Relative effect per patient (REPP)--outcome groups for total hip replacement and total knee replacement].
Huber J; Dabis E; Zumstein MD; Hüsler J
Z Orthop Unfall; 2013 Jun; 151(3):239-42. PubMed ID: 23696160
[TBL] [Abstract][Full Text] [Related]
5. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
Pham T; van der Heijde D; Altman RD; Anderson JJ; Bellamy N; Hochberg M; Simon L; Strand V; Woodworth T; Dougados M
Osteoarthritis Cartilage; 2004 May; 12(5):389-99. PubMed ID: 15094138
[TBL] [Abstract][Full Text] [Related]
6. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs.
Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L
J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
Osteoarthritis Cartilage; 2005 Feb; 13(2):104-10. PubMed ID: 15694571
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after total hip replacement based on patients' baseline status: what results can be expected?
Quintana JM; Aguirre U; Barrio I; Orive M; Garcia S; Escobar A
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):563-72. PubMed ID: 22183807
[TBL] [Abstract][Full Text] [Related]
9. The Inverse OARSI-OMERACT Criteria Is a Valid Indicator of the Clinical Worsening of Knee Osteoarthritis: Data From the Osteoarthritis Initiative.
Driban JB; Harkey MS; Price LL; Lo GH; McAlindon TE
J Rheumatol; 2021 Mar; 48(3):442-446. PubMed ID: 32541081
[TBL] [Abstract][Full Text] [Related]
10. Total knee replacement; minimal clinically important differences and responders.
Escobar A; García Pérez L; Herrera-Espiñeira C; Aizpuru F; Sarasqueta C; Gonzalez Sáenz de Tejada M; Quintana JM; Bilbao A
Osteoarthritis Cartilage; 2013 Dec; 21(12):2006-12. PubMed ID: 24095837
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trial.
Gooch K; Marshall DA; Faris PD; Khong H; Wasylak T; Pearce T; Johnston DW; Arnett G; Hibbert J; Beaupre LA; Zernicke RF; Frank C
Osteoarthritis Cartilage; 2012 Oct; 20(10):1086-94. PubMed ID: 22796513
[TBL] [Abstract][Full Text] [Related]
12. Willingness to go through surgery again validated the WOMAC clinically important difference from THR/TKR surgery.
Chesworth BM; Mahomed NN; Bourne RB; Davis AM;
J Clin Epidemiol; 2008 Sep; 61(9):907-18. PubMed ID: 18687289
[TBL] [Abstract][Full Text] [Related]
13. A new responder criterion (relative effect per patient (REPP) > 0.2) externally validated in a large total hip replacement multicenter cohort (EUROHIP).
Huber J; Hüsler J; Dieppe P; Günther KP; Dreinhöfer K; Judge A
Osteoarthritis Cartilage; 2016 Mar; 24(3):480-3. PubMed ID: 26518993
[TBL] [Abstract][Full Text] [Related]
14. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.
Pham T; Van Der Heijde D; Lassere M; Altman RD; Anderson JJ; Bellamy N; Hochberg M; Simon L; Strand V; Woodworth T; Dougados M;
J Rheumatol; 2003 Jul; 30(7):1648-54. PubMed ID: 12858473
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of primary total knee arthroplasty: the impact of patient-relevant factors on self-reported function and quality of life.
Kauppila AM; Kyllönen E; Ohtonen P; Leppilahti J; Sintonen H; Arokoski JP
Disabil Rehabil; 2011; 33(17-18):1659-67. PubMed ID: 21184628
[TBL] [Abstract][Full Text] [Related]
16. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.
Gossec L; Paternotte S; Maillefert JF; Combescure C; Conaghan PG; Davis AM; Gunther KP; Hawker G; Hochberg M; Katz JN; Kloppenburg M; Lim K; Lohmander LS; Mahomed NN; March L; Pavelka K; Punzi L; Roos EM; Sanchez-Riera L; Singh JA; Suarez-Almazor ME; Dougados M;
Osteoarthritis Cartilage; 2011 Feb; 19(2):147-54. PubMed ID: 21044689
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.
Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
Ann Rheum Dis; 2005 Jan; 64(1):34-7. PubMed ID: 15130902
[TBL] [Abstract][Full Text] [Related]
18. Determinants of willingness to pay for hip and knee joint replacement surgery for osteoarthritis.
Cross MJ; March LM; Lapsley HM; Tribe KL; Brnabic AJ; Courtenay BG; Brooks PM
Rheumatology (Oxford); 2000 Nov; 39(11):1242-8. PubMed ID: 11085804
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes one year after primary hip replacement in a European Collaborative Cohort.
Judge A; Cooper C; Williams S; Dreinhoefer K; Dieppe P
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):480-8. PubMed ID: 20391502
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the responsiveness of the ICOAP following hip or knee replacement.
Davis AM; Lohmander LS; Wong R; Venkataramanan V; Hawker GA
Osteoarthritis Cartilage; 2010 Aug; 18(8):1043-5. PubMed ID: 20435154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
